TipRanks
Advertisement
Advertisement

DE:XE9 Stock Latest News

Xencor price target raised to $26 from $20 at BofA
The FlyXencor price target raised to $26 from $20 at BofA
17d ago
XNCR
Xencor price target raised to $35 from $27 at Barclays
PremiumThe Fly
Xencor price target raised to $35 from $27 at Barclays
27d ago
XNCR
Xencor price target raised to $21 from $14 at JPMorgan
PremiumThe Fly
Xencor price target raised to $21 from $14 at JPMorgan
1M ago
XNCR
Xencor price target raised to $46 from $40 at Raymond James
PremiumThe Fly
Xencor price target raised to $46 from $40 at Raymond James
1M ago
XNCR
Analyst John Newman Reiterates Buy on Xencor, Citing Late-Stage XmAb Pipeline, Non-Dilutive Cash Inflows and Royalties, and Sets $38 Price Target
PremiumRatings
Analyst John Newman Reiterates Buy on Xencor, Citing Late-Stage XmAb Pipeline, Non-Dilutive Cash Inflows and Royalties, and Sets $38 Price Target
2M ago
XNCR
Xencor price target raised to $30 from $26 at Wedbush
PremiumThe FlyXencor price target raised to $30 from $26 at Wedbush
2M ago
XNCR
Xencor price target raised to $44 from $43 at Cantor Fitzgerald
Premium
The Fly
Xencor price target raised to $44 from $43 at Cantor Fitzgerald
2M ago
XNCR
Xencor price target raised to $20 from $19 at RBC Capital
Premium
The Fly
Xencor price target raised to $20 from $19 at RBC Capital
2M ago
XNCR
Xencor: Buy Rating Backed by XmAb819 Expansion and Immunology Pipeline Milestones Ahead of Key 2026–2027 Data Catalysts
PremiumRatings
Xencor: Buy Rating Backed by XmAb819 Expansion and Immunology Pipeline Milestones Ahead of Key 2026–2027 Data Catalysts
2M ago
XNCR
Xencor Earns Buy Rating as XmAb541 and XmAb808 Advance Toward Differentiated Solid-Tumor Franchise
PremiumRatings
Xencor Earns Buy Rating as XmAb541 and XmAb808 Advance Toward Differentiated Solid-Tumor Franchise
2M ago
XNCR
Xencor reports Q2 EPS (29c), consensus (84c)
PremiumThe Fly
Xencor reports Q2 EPS (29c), consensus (84c)
2M ago
XNCR
Xencor participates in a conference call with Cantor
PremiumThe Fly
Xencor participates in a conference call with Cantor
2M ago
XNCR
Xencor Inc. (XNCR) Q2 Earnings Cheat Sheet
PremiumPre-EarningsXencor Inc. (XNCR) Q2 Earnings Cheat Sheet
2M ago
XNCR
Xencor Secures Ultomiris Royalty Settlement Payment
Premium
Company Announcements
Xencor Secures Ultomiris Royalty Settlement Payment
2M ago
8K
XNCR
Xencor to receive $105M from Alexion to resolve Ultomiris royalty matter
Premium
The Fly
Xencor to receive $105M from Alexion to resolve Ultomiris royalty matter
2M ago
XNCR
Xencor price target lowered to $27 from $29 at Truist
PremiumThe Fly
Xencor price target lowered to $27 from $29 at Truist
3M ago
XNCR
Xencor Shareholders Approve Directors, Incentive Plan Amendments
PremiumCompany Announcements
Xencor Shareholders Approve Directors, Incentive Plan Amendments
4M ago
8K
XNCR
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe Fly
Acting FDA head vows to block political interference, Endpoint News says
4M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
4M ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe FlyTrump Trade: Trump to suspend tariff-rate quotas on beef imports
5M ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
Premium
The Fly
Trump Trade: U.S. plans AI security order without required model tests
5M ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
Premium
The Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
5M ago
DYN
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >